Home/Rare Diseases/Tick-Borne Relapsing Fever

Tick-Borne & Infectious

Tick-Borne Relapsing Fever (TBRF) Clinical Trials

Also called TBRF, Soft tick relapsing fever, STRF, Borrelia hermsii infection, Borrelia turicatae infection

Tick-borne relapsing fever, which the CDC now calls soft tick relapsing fever, is caused by several Borrelia species that are relatives of the Lyme disease bacterium but behave very differently. They are spread by soft-bodied ticks that live in the nests of rodents such as chipmunks and squirrels, often inside the walls and under the floors of rustic cabins.

View 1 active trialMatch me to a trial

About Tick-Borne Relapsing Fever

Tick-borne relapsing fever, which the CDC now calls soft tick relapsing fever, is caused by several Borrelia species that are relatives of the Lyme disease bacterium but behave very differently. They are spread by soft-bodied ticks that live in the nests of rodents such as chipmunks and squirrels, often inside the walls and under the floors of rustic cabins. The bacteria repeatedly change their surface proteins to escape the immune system, which is why the fever comes back in waves.

Symptoms begin 4 to 21 days after exposure. Each fever episode lasts about 3 days, separated by about a week without fever. Because the bacteria are present in large numbers in the blood during a fever, the diagnosis is usually made by looking at a stained blood smear under a microscope, something most hospital labs can do. PCR is available from some commercial labs. One trap: relapsing fever can cause a false positive Lyme disease antibody test, so a positive Lyme test in someone with cyclic fevers after a cabin stay deserves a second look.

Treatment for adults is 10 days of doxycycline, or azithromycin, penicillin G or ceftriaxone, with intravenous beta-lactam antibiotics first for pregnant patients or anyone with neurological involvement. Up to half of patients have a Jarisch-Herxheimer reaction within hours of the first dose, a sudden spike of fever, chills and low blood pressure as bacteria die, so the CDC advises observing patients for the first 4 hours. The infection can cross the placenta, and pregnant women who may have been exposed should be evaluated promptly.

Common Symptoms of Tick-Borne Relapsing Fever

Recognizing the signs of Tick-Borne Relapsing Fever early can lead to faster diagnosis and better outcomes. Symptoms may vary in severity from person to person. If you or a loved one are experiencing any of the following, consider speaking with a specialist.

  • Fever of around 3 days, then about 7 days without fever, then fever again, sometimes several times
  • Headache, muscle aches and chills during each fever
  • Dizziness, joint pain, nausea and loss of appetite
  • Shaking, drenching sweats and low blood pressure as each fever breaks
  • Rarely, facial paralysis, eye pain or vision changes
  • Pregnancy loss, premature birth or severe newborn infection when it occurs in pregnancy

Who Tick-Borne Relapsing Fever Affects

People who sleep in rodent-infested cabins and vacation homes in the mountains of the western states, where Borrelia hermsii is carried by Ornithodoros hermsi ticks, and people who explore caves in Texas, where Borrelia turicatae is carried by Ornithodoros turicata. The bites are painless, last under half an hour and usually happen at night, so most patients never saw a tick. Exposure is most common in summer but can happen in winter when cabins are heated.

Find Your Next Step

Answer a few questions and we'll point you to the right tools and information for where you are right now.

Where are you in your Tick-Borne Relapsing Fever journey?

FDA-Approved Treatments for Tick-Borne Relapsing Fever

There is currently 1 FDA-approved medication for Tick-Borne Relapsing Fever. These therapies represent the current standard of care and may be used alongside or compared against investigational treatments in active clinical trials.

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

Ask about these treatments
Answers with sources, in plain English
Start withor ask

Help Paying for Tick-Borne Relapsing Fever Treatment

Charity funds and drugmaker programs for Tick-Borne Relapsing Fever, checked at the source.

Which insurance do you have? Pick one to see what fits. Tap it again to clear.
Your insurance
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Open the full patient assistance finder →

Side Effect Explorer

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Questions about side effects?
I can help you understand what these reports mean
Start withor ask

Diagnosis and Testing

Bacterial infection (Borrelia hermsii or B. turicatae) from soft tick bites, diagnosed by blood smear or PCR; not genetic.

Trusted Tick-Borne Relapsing Fever Resources

Reputable organizations and medical references for learning more about Tick-Borne Relapsing Fever, including disease registries, foundation resources, and clinical guidelines.

Active Clinical Trials for Tick-Borne Relapsing Fever

Use this Tick-Borne Relapsing Fever clinical trial finder to see the 0 studies recruiting patients and 1 opening soon in the United States and worldwide, with eligibility criteria in plain English. These studies play a critical role in advancing care for tick-borne & infectious conditions and may offer access to treatments not yet widely available. Each trial below is sourced directly from ClinicalTrials.gov, with eligibility criteria translated into plain English to help patients and caregivers evaluate whether a study may be a fit.

TrialsSite mapPipeline timeline

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

1 active trial worldwide
Filter:
Sort:
NOT YET RECRUITINGNAHasn't posted an update in over a yearNCT06045481

Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever

Intervention: administration of single dose of doxycycline

Sponsor: Medical Corps, Israel Defense Force

The goal of this clinical trial is to compare standard treatment (5 days of doxycycline) vs single dose doxycycline for the prevention of tick-borne relapsing fever in soldiers who found bite marks on their bodies after an activity that includes contact with the ground or staying...

Ages 18 Years – 30 Years
Expected to start Aug 2024Updated 2 years agoEst. Oct 2026 (19 days)
Get Tick-Borne Relapsing Fever alerts by email

One email when something new happens for Tick-Borne Relapsing Fever, never a newsletter.

You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Tick-Borne Relapsing Fever. Turn any of these off from the link in every email.

We never share your email. Unsubscribe anytime. Privacy policy
Find Tick-Borne Relapsing Fever trials near you, ranked by distance →
Active trial locationslocations pending
Trial site locations haven't been published yetThese trials are likely still setting up their study locations. See the trial cards below for details, or check back soon for updated locations.

Trial Pipeline

Aug 2024 to Oct 2027
2025
2026
2027
now
Observational
RecruitingOpening soonDelayed startTodayHover a bar for trial details
Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Tick-Borne Relapsing Fever foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Patient Communities

Connect with other Tick-Borne Relapsing Fever patients, caregivers, and advocacy groups across Facebook groups, Reddit communities, and YouTube channels. These patient communities offer peer support, shared experiences, caregiver resources, and real-time discussion about Tick-Borne Relapsing Fever treatments, clinical trial participation, and day-to-day disease management.

Find the right community
Answers with sources, in plain English
Start withor ask

Related Tick-Borne & Infectious Conditions

Other rare diseases in the tick-borne & infectious category. Patients with Tick-Borne Relapsing Fever may find relevant research, shared treatment pathways, or overlapping clinical trials among these related conditions.

Frequently Asked Questions About Tick-Borne Relapsing Fever